Securities Code: 300119
Securities Abbreviation: Ruipu Bio
Announcement No.: 2026-033
Ruipu Bio Pharmaceutical Co., Ltd.
Announcement on Winning the Second Prize of the National Science and Technology Progress Award
The Company and the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Ruipu Bio Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") and its holding subsidiary Guangzhou South China Agricultural University Bio-Pharmaceutical Co., Ltd. (hereinafter referred to as "South China Bio") participated in the project "Innovation and Source Control Key Technologies and Application of Avian Influenza Vaccines," which recently won the second prize of the National Science and Technology Progress Award.